Juvenescence Closes First Tranche of Series B Enabling Further Growth and Development

Retrieved on: 2019-01-15 16:15:00

Tags for this article:

Ageing

Biotechnology

Demography

Economy of the United Kingdom

Click the tags to see associated articles and topics

Juvenescence Closes First Tranche of Series B Enabling Further Growth and Development. View article details on hiswai:

Excerpt

<div>... 2017, Juvenescence has built a diverse pipeline of ageing-related assets, formed joint ventures with AI companies <b>Insilico Medicine</b> and Netramark, ...</div>

Article found on:

View Original Article